The anti-mouse and anti-guinea pig antilymphocyte sera (ALS) prepared for this study were shown to contain cytoxic and leucoagglutinating antibodies, and were capable of producing severe lymphopenia in these animals. Guinea pigs treated weekly with ALS were more susceptible to development of fatal infection when inoculated with Histoplasma capsulatum. No fatalities occurred in guinea pigs infected with equal doses of H. capsulatum but treated with normal rabbit serum (NRS) or saline. The time necessary to reach 50% fatality in mice infected with Cryptococcus neoformans was greatly reduced by pretreatment with ALS in comparison with infected controls treated with NRS or saline. When low dosages were used (0.1 LDSo), the effect was even more pronounced. Spleen homogenates from mice infected with equal dosages of H. capsulatum and treated with ALS or NRS were cultured. More than 150 times as many organisms were present in the spleens of the ALS-treated group. Similar results were obtained from culturing the lungs and liver. Delayed hypersensitive skin reactions were radically decreased or abrogated in H. capsulatum-infected guinea pigs inoculated intraperitoneally with ALS 12 hr before skin testing with histoplasmin. When ALS was given weekly, the influence on skin reactivity was less notable. Given intradermally, ALS was shown to inhibit the delayed reaction to histoplasmin within a radius of 40 mm.
Antilymphocyte serum (ALS) is a potent immunosuppressive agent. Although there have been a number of studies concerning the mode of action of ALS (6, (11) (12) (13) , its exact mechanism is not fully understood. Administration of ALS characteristically results in a lymphopenia (4, 5, 17, 19) . Lymphoagglutination and lymphocytolysis occur in vitro in the presence of ALS. Such immunologic events are likely associated with the in vivo production of lymphopenia which characteristically follows treatment with ALS. ALS has been shown to inhibit cutaneous delayed hypersensitive reactions (19) , prolong the survival of various tissue and organ grafts (1, 18) , and depress primary humoral immunologic responses (15) .
Treatment with ALS renders an animal more susceptible to exogenous infection and probably to endogenous infection as well. Abaza et al. (1) reported that four of eight dogs treated with ALS died from infection: two from distemper, one from hepatitis, and one of pneumonia.
Experimental bacterial or mycotic infections in conjunction with ALS treatment have not been reported. This study was designed to assess the effect of ALS on the degree of susceptibility of laboratory animals to experimental infection by two fungal organisms: Histoplasma capsulatum and Cryptococcus neoformans. The effect of ALS on the delayed hypersensitive skin reaction produced by infection with H. capsulatum was also investigated.
MATERIALS AND METHODS Animals used. Five-to seven-week-old female, English Short Hair guinea pigs were used as lymphocyte donors. Twelve-week-old guinea pigs were used for infection studies and treatment with ALS. The mice used were Swiss hybrids of both sexes which are maintained in our laboratory. New Zealand rabbits weighing 2 to 3 kg were used for the production of all ALS used in this study.
Organisms (16) . Preparation of ALS. Two different preparations were used in this study, but both were prepared in essentially the same manner. Rabbit anti-guinea pig and anti-mouse lymphocyte serum was prepared by removing the thymuses of 5-to 7-week-old guinea pigs and 3-to 4-week-old mice, respectively. The organs were vein-stripped and carefully pressed through a fine stainless-steel mesh into cold saline. The lymphocytes were then washed three times in cold saline and resuspended to a concentration of 5 X 108 cells/ml. New Zealand rabbits were inoculated intravenously with 2 ml of the suspension. Two weeks later the procedure was repeated, and the following week all rabbits were bled. The serum was heated at 56 C for 30 min, filtersterilized, cultured for sterility, and stored at -20 C until used.
Leucoagglutination tests. A modification of the method of Amos and Peacocke (3) was used. Lymphocyte preparations were washed in saline three times, and the cells were then diluted to 2 X 107 cells/ml in buffer, pH 7. Equal volumes (0.1 ml) of cells and serial dilutions of serum were mixed in tubes (9 X 75 mm) and read for macroscopic agglutination after standing for 2 hr at room temperature.
Cytotoxicity tests. A method similar to that described by Gray et al. (9) was used. The cytotoxic activity of ALS was determined by mixing a lymphocyte suspension in saline with an equal amount of ALS, adding a drop of 1:10 dilution of complement, and incubating the mixture for 30 min at 37 C. Trypan blue (0.2%) was added and the viability was determined by counting the dead (stained) and living (unstained) cells.
White blood cell (WBC) and differential counts. All guinea pigs were bled by cardiac puncture prior to treatment. WBC and differential counts were done and were repeated at weekly intervals thereafter. Mice were subjected to total WBC and differential counts before and after ALS treatment.
Precipitin tests. All sera from weekly bleedings of the guinea pigs involved were tested in agar gel against crude histoplasmin antigens prepared as described earlier (2) . The plates were observed daily for 14 days. Infection of guinea pigs with H. capsulatum and serum treatment. The mycelial phase was used for inoculation of guinea pigs. One-month-old cultures were harvested from Sabouraud agar slants (2% glucose used throughout the study) into sterile saline, ground with a Teflon grinder, and diluted to give 107 particles/ml (single, or clumps of conidia with or without hyphal fragments). Guinea pigs were inoculated intraperitoneally with 1 ml of the above suspension. Plating of appropriate dilutions on Sabouraud agar showed that this dosage represented 9 X 105 viable particles. Four groups of guinea pigs (10 per group) were inoculated with this dosage. Group one received two injections of ALS before infection with H. capsulatum and weekly injections thereafter. Group two received the same treatment, but normal rabbit serum (NRS) was used rather than ALS. Groups three and four were treated with saline on the same schedule as the other two groups, except that group four received an injection of ALS 12 hr before skin testing.
Infection of mice with H. capsulatum. The 110 eightweek-old mice used were placed in three main divisions. The first division consisted of 40 mice, 10 per group. Each of these mice received 0.25 ml of ALS intraperitoneally the day before, the day of, and the day after (days -1, 0, and 1) infection on day 0. Half of the mice in this division received 7 X 106 viable yeast cells of H. capsulatum intravenously and the remainder received 7 X 104 viable cells intravenously. Viability was calculated to be 70% by plating the cells from a 2-day-old culture on Sabouraud agar.
The second division also consisted of 40 mice. These mice were treated as above except that NRS was used instead of ALS.
The third division consisted of 30 mice. Ten mice were given 7 X 106 viable yeast cells intravenously, and 20 received 7 X 104 viabl e cells. All mice were then inoculated as above except that saline was used rather than serum.
Half of the members of a duplicate set of 30 mice which had been treated with ALS, NRS, or saline and inoculated with 7 X 104 viable yeast cells were autopsied 2 weeks postinfection. The remaining 15 mice were autopsied 2 weeks later. The spleens, livers, and lungs were quantitatively cultured on Sabouraud agar.
Infection of mice with C. neoformans. In these tests, 140 eight-week-old mice were used. The mice were placed in three main divisions. The first division consisted of 70 mice, each of which received three intraperitoneal injections of ALS (0.25 ml/dose). Forty of the mice in the first division were given ALS on days -1, 0, and 1. Twenty of these were inoculated with 2.2 X 105 cells (1 LD5o) and 20 with 2.2 X 104 cells (0.1 LD5o) of C. neoformans. The inoculum was prepared by growing cells for 3 days at 30 C with constant shaking in neopeptone dextrose dialysate broth (7), and the viability was calculated to be 90% by plating cells on quadruplicate plates of Sabouraud agar. Ten mice received nonviable cells (2% Formalin and heat-killed), and 10 received no cells (ALS control). Ten additional mice were given 1 LD5o on day 0 but were treated with ALS on days 7, 8, and 9. In the second division, the treatment of mice was similar except that NRS was used instead of ALS.
In the third division, two groups were used. The first group was given 1 LD5o; the second group received one-tenth of this dosage. All mice were treated with saline rather than ALS.
Skin tests in guinea pigs infected with H. capsulatum. Four groups of 10 guinea pigs inoculated 4 weeks earlier with 9 X 106 viable mycelial particles and treated with ALS as stated previously were used. Skin testing was performed by injecting 0.1 ml of a 1:25 dilution of histoplasmin (lot H-42, produced by the Public Health Service) intradermally into shaved abdominal sites. Determination of local inhibition of delayed hypersensitivity. To determine whether delayed-type hypersensitivity could be inhibited locally by intradermal injection of ALS, 10 guinea pigs with known dermal sensitivity were used. On one side, histoplasmin, 1:25 dilution, was inoculated intradermally. At distances of ANTILYMPHOCYTE SERUM AND FUNGUS INFECTIONS 25 to 50 mm from this site, ALS was given intradermally. A second injection of histoplasmin was given as a control at least 100 mm distant from the ALS injection site. Induration and erythema were measured at 24 and 48 hr.
RESULTS
Leucoagglutination tests. The leucoagglutination titer of rabbit anti-guinea pig lymphocyte serum was 1: 512, and for rabbit anti-mouse lymphocyte serum, 1:256. Guinea pig or mouse lymphocytes in buffer alone or in buffer plus NRS were not agglutinated.
Cytotoxicity tests. Fifty per cent of the lymphocytes exposed to rabbit anti-guinea pig lymphocyte serum were killed within 30 min, compared with 6% in controls containing NRS. After 30 min of exposure to rabbit anti-mouse lymphocyte serum, 57 % of the lymphocytes were killed, compared with 10% for controls containing NRS.
WBC counts. Normal WBC counts for guinea pigs used were in a range of 3,500 to 13,000/mm3, with most of the animals having a count of 7,000 a 3,000/mm3. Hematological findings in guinea pigs infected with H. capsulatum and treated with ALS are shown in Fig. 1 .
The WBC counts of normal mice ranged from 6,200 to 19,600/mm3. After three daily intra- peritoneal injections of ALS, 0.25 ml each, the total WBC count had increased from 9,100/mm3 (mean) to 19,700/mm3. White counts returned to values close to normal in 10 days.
Differential blood counts. Guinea pigs treated with ALS showed a marked decrease in percentage of lymphocytes within 24 hr. Lymphopenia was at its maximum (14%) after 2 weeks of ALS treatment. The lymphocyte count began to return toward normal by the third week (Fig. 2) .
Triplicate differential counts performed on 20 normal mice revealed the following mean values: neutrophils, 21 %; lymphocytes, 74%; monocytes, 4%; eosinophils, 1%. After three consecutive doses of ALS given intraperitoneally, the following averages were obtained: neutrophils, 56%; lymphocytes, 38%; monocytes, 3%; eosinophils, 3%.
Precipitin tests. Only four of 35 guinea pigs infected with H. capsulatum had sera that reacted positively with crude histoplasmin. One animal which had a positive response had been treated weekly with ALS; the other three animals which had responded positively had been treated with saline. In mice which received a low number of viable cells (7 X 104), no deaths had occurred by the end of 3 weeks in any group (ALS, NRS, or saline). Autopsies were performed at 2 and 4 weeks postinfection on a portion of the mice that had received the low dose of cells. Mice treated with ALS had a number of characteristics not seen in mice treated with NRS or saline. Hepatosplenomegaly was common, and their livers were discolored and had a mottled appearance. Culturing of these organs showed far more extensive invasion of H. capsulatum. Over 150 times as many colonies were isolated as from spleens of mice treated with NRS. Similar effects were seen in the livers and lungs of these animals. NRS-treated mice had fewer organisms present in their organs than did the other two groups. This seeming protection was perhaps due to stimulation or enhancement of some part of the immune process which was not performed by ALS. Quantitative results are shown in Table  2 .
Infection of mice with C. neoformans. Mice treated with ALS on days -1, 0, and 1, and infected with 1 LD50 died more rapidly than any other group. On day 17 (postinfection) 50% of the mice in this group were dead. Mice infected with 0.1 LD5o had 50% deaths on day 24, compared with no deaths in the group which received the same infective dose but were treated with saline rather than ALS. Mice which were infected on day 0 and treated on days 7, 8, and 9 with ALS had the same 28-day mortality (90%) as did the group that was treated on days -1, 0, and 1. Complete details are shown in Table 3 .
Effect of intraperitoneal inoculation of AIS on delayed-type hypersensitivity. Little effect was produced by weekly injections of guinea pigs with ALS. The mean induration of skin test readings was 7.6 X 8.2 mm. This was somewhat less than for animals treated with NRS weekly (10.1 x 11.1 mm) or saline (11.4 X 11.4 mm). Marked suppression was exhibited, however, in the group which received only one injection of ALS 12 hr before skin testing. The mean 24-hr induration for this group was 1.7 x 1.8 mm. The mean values for 24-and 48-hr skin test readings are given in Table 4 .
Effect of ALS given intradermally on delayedtype hypersensitivity. In guinea pigs infected with H. capsulatum, ALS given intradermally markedly depressed the delayed skin reaction. As can be seen in Table 5 , the effects of ALS were not limited to a small area around the site of injection. Skin reactivity to histoplasmin was inhibited, usually completely, within a radius of 40 mm. At distances greater than 40 mm, little or no effect on skin test reactivity was apparent. The suppressive effect was still evident at 48 hr but had usually disappeared within 72 hr.
DISCUSSION
It has been shown that treatment with ALS had a marked effect on mortality resulting from experimental infection. Fifty per cent of the a ALS = antilymphocyte serum; NRS = normal rabbit serum. All treatments consisted of the intraperitoneal injection of three 0.25-ml doses on the day before, the day of, and the day after infection. guinea pigs which were treated weekly with ALS died during the study.
Findings in mice were similar. Mice treated with ALS and given 1 LD60 of C. neoformans died much sooner than infected controls given NRS or saline.
Mice which were not experimentally infected but were treated with ALS were somewhat more susceptible to observable infection from agents in the environment than were normal, untreated mice. Three of 10 mice treated with ALS and given nonviable cryptococci died. Negative organ and blood cultures suggested a possible viral etiology. Volkert and Lundstedt (20) observed that mouse-lymphocytic choriomeningitis I U.Lz) ml/injection; NKb = normai ranuit serum, onviable. itted. sis.
An inference which may be drawn from this predisposition to mortality is that ALS presumably inhibited or destroyed antibody-forming cells which would have ordinarily become committed to the infecting organism. The cells inhibited by ALS would presumably be lymphocytes, including many which would be uncommitted. Thus, owing to depletion of immunologically competent cells during the time of antigenic stimulation, an impairment might result in the cellular immune mechanism. Such impairment could play a role in the extreme proliferation of H. capsulatum which occurred in various organs of ALS-treated mice. This marked increase in the extent of tissue invasion provides some evidence that the cellular immune response is an important mechanism in limiting histoplasmosis to its typically benign form. This was substantiated in part by our observation that delayed hypersensitivity (a manifestation of cellular immunity) was markedly inhibited by intradermal administration of ALS. This impairment of the immune system does not stem from competition of antigens (i.e., ALS with H. capsulatum yeast cells), for if this were so mice treated with NRS should have more-not fewer-organisms isolated per organ than those mice treated with saline.
The exact mechanisms involved in the delayed hypersensitive skin reaction remain unknown. It seems likely that a small number of immunologically committed lymphocytes trigger the response upon re-exposure to specific antigen (8, 14) . Once initiated, the typical mononuclear cellular infiltration follows. This reaction is greatly decreased or abolished in the presence of ALS. It can be speculated that ALS effectively removes or greatly diminishes these committed lymphocytes (by opsonization and phagocytosis, immunocytolysis, or some other means), thereby eliminating the initial triggering mechanism of the delayed response.
